The dental 3D printing market is anticipated to grow at a CAGR of 15.1% during the period 2023-2035, claims Roots Analysis The growing burden of dental diseases and the challenges associated with the conventional dental product manufacturing methods has significantly increased the adoption of 3D printing in the dental industry For additional details, please visit https://www.rootsanalysis.com/reports/dental-3d-printing-market.html

The global digital twins market is projected to grow at a CAGR of 30% till 2035, claims Roots Analysis Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain For additional details, please visit https://www.rootsanalysis.com/reports/digital-twins-market.html

DRIVEN BY THE GROWING DEMAND FOR MEDICAL DEVICES, NOVEL COATINGS PROVIDING UNIQUE FEATURES ARE BEING INTRODUCED IN THE MARKET Over the past 50 years, the medical device industry has seen several notable developments. In fact, the use of biomedical devices, such as medical implants, surgical instruments, and prostheses has increased substantially over the time. For additional details, please visit https://www.rootsanalysis.com/reports/medical-device-coatings-market.html

The clinical trials software market is projected to be growing at a CAGR of 14%, claims Roots Analysis Given the limitations of current clinical trial approaches, including inefficient patient management and data handling, trial sponsors are increasingly opting for innovative technologies and software solutions for conducting clinical trials For additional details, please visit https://www.rootsanalysis.com/reports/clinical-trial-software-market.html

The liposome development and manufacturing services market is anticipated to grow at a CAGR of nearly 10% till 2035, claims Roots Analysis Driven by the development of advanced methods for preparation and characterization of liposomes, and the application of these molecules in therapeutics and diagnostics, the demand for liposomes is expected to rise in the coming years. For additional details, please visit https://www.rootsanalysis.com/reports/liposome-manufacturing-market.html

More than 740 RNA Extraction and Purification Kits are Commercially Available in the Market Amongst the total players involved in the development of RNA extraction and purification kits and reagents, majority of the players engaged in the development of RNA extraction and purification kits were established between 1981-2000. For additional details, please visit https://www.rootsanalysis.com/reports/rna-extraction-and-purification.html

RNAi THERAPY OFFERS THE POTENTIAL TO REVOLUTIONIZE THE BIOPHARMACEUTICAL INDUSTRY Owing to their vast potential in controlling disease-associated gene expression, RNAi therapeutics have emerged as a key segment of the market; several big pharma players have undertaken RNAi focused initiatives. For additional details please visit https://www.rootsanalysis.com/reports/view_document/rnai-therapeutics-market/278.html

The rare kidney disorders market is projected to grow at a CAGR of 17%, during the period 2022-2035, claims Roots Analysis Considering the rising unmet need associated with rare kidney disorders and the growing adoption of available treatment options, industry stakeholders have made significant investments to enable the development of novel drug candidates targeting this set of rare diseases. For additional details, please visit https://www.rootsanalysis.com/reports/rare-kidney-diseases-market.html

The at-home self-testing kits market is projected to grow at a healthy pace, till 2035, claims Roots Analysis Driven by the various advantages offered by at-home self-testing kits and the growing awareness and adoption of such products post the onset of the COVID-19 outbreak, this market is abuzz with activity to develop kits for detection, diagnosis and screening purposes. For additional details, please visit https://www.rootsanalysis.com/reports/self-testing-kits-market.html

THE PHARMACEUTICAL INDUSTRY IS PRESENTLY EXPERIENCING A PROMINENT NEED FOR BIOAVAILABILITY ENHANCEMENT TECHNOLOGIES AND SERVICES Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/bioavailability-enhancement-technologies-and-services/198.html